PDF Cover

Intravascular Brachytherapy System Market

The market for Intravascular Brachytherapy System was estimated at $657 million in 2024; it is anticipated to increase to $937 million by 2030, with projections indicating growth to around $1.26 billion by 2035.

Report ID:DS1801177
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Intravascular Brachytherapy System
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Intravascular Brachytherapy System Market Outlook

Revenue, 2024

$657M

Forecast, 2034

$1.19B

CAGR, 2025 - 2034

6.1%

The Intravascular Brachytherapy System (IVBT) industry revenue is expected to be around $697.1 million in 2025 and expected to showcase growth with 6.1% CAGR between 2025 and 2034. The strong upward trend of the Intravascular Brachytherapy System reflects a change in the medical field towards cutting edge and inventive treatment methods. This increase in market worth is linked to factors like the increasing needs, in cardiology and the rising occurrence of coronary artery diseases globally. Research & development advancements and the popularity of invasive techniques also play crucial roles in maintaining the importance of this system.

The Intravascular Brachytherapy System, also known as Intracoronary Brachytherapy, is a medical tool that utilizes controlled radiation to address blockages in blood vessels within the field of cardiovascular treatments - particularly targeting issues like in stent restenosis. Increasing interest in this system stems from advancements in catheter based devices technology and its growing acceptance among healthcare facilities and the move towards personalized treatment strategies, through precision medicine principles.

Intravascular Brachytherapy System market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Intravascular Brachytherapy System Market Outlook

Market Key Insights

  • The Intravascular Brachytherapy System market is projected to grow from $657.0 million in 2024 to $1.19 billion in 2034. This represents a CAGR of 6.1%, reflecting rising demand across Angioplasty Treatment, Peripheral Artery Disease Management, and Coronary Heart Disease Treatment.

  • Boston Scientific Corporation, Varian Medical Systems Inc., Elekta AB are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Intravascular Brachytherapy System market and are expected to observe the growth CAGR of 4.0% to 5.9% between 2024 and 2030.

  • Emerging markets including India, Brazil and Malaysia are expected to observe highest growth with CAGR ranging between 7.0% to 8.4%.

  • Transition like Increasing Adoption of NonInvasive Alternatives has greater influence in U.S. and Germany market's value chain; and is expected to add $24 million of additional value to Intravascular Brachytherapy System industry revenue by 2030.

  • The Intravascular Brachytherapy System market is set to add $531 million between 2024 and 2034, with manufacturer targeting Specialty Clinics & Outpatient Facilities Application projected to gain a larger market share.

  • With

    advancements in technology, and

    Increased Demand Due to Prevalence of Cardiovascular Diseases, Intravascular Brachytherapy System market to expand 81% between 2024 and 2034.

intravascular brachytherapy system market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Intravascular Brachytherapy System - Country Share Analysis

Opportunities in the Intravascular Brachytherapy System

Expanding the reach of Intravascular Brachytherapy Systems to areas with access could lead to notable growth opportunities in markets like developing countries where healthcare facilities are improving and awareness about vascular conditions is also rising. Making them ideal for the adoption of advanced treatment options such, as Intravascular Brachytherapy Systems.

Growth Opportunities in North America and Asia-Pacific

North America plays a role in the worldwide market for Intravascular Brachytherapy Systems with its strong focus on cutting edge technology and top tier companies fostering intense competition in the region. The enhanced healthcare facilities and better insurance options are fueling the growing interest in Intravascular Brachytherapy Systems here. Additionally the increasing instances of artery diseases and coronary artery diseases have transformed North America into a profitable market, for Intravascular Brachytherapy Systems.
In the Asia Pacific region specifically the Intravascular Brachytherapy System market is expected to experience growth. Countries like China and India are presenting prospects as cardiovascular diseases become more prevalent and the elderly population expands. Moreover the rising healthcare infrastructure investments and increasing awareness of cardiovascular treatments are encouraging the adoption of Intravascular Brachytherapy Systems in this region. The growth in income and enhancements, in healthcare insurance policies are also projected to drive progress in this part of the world.

Market Dynamics and Supply Chain

01

Driver: Advancements in Technology, and Favorable Reimbursement Policies

The progress in technology has also brought about the creation of Intravascular Brachytherapy Systems that are also set to boost growth in the field by providing more precise treatment and better outcomes for patients. The integration of Vascular  imaging and computer support in these systems allows for more accurate radiation targeting and reduces the chances of harming nearby tissues. This enhanced and focused approach has also established Intravascular Brachytherapy as a favored option, for managing artery disease pushing forward market expansion. Reimbursement guidelines play a role in the healthcare device markets dynamics. In areas across the globe; insurance policies often include coverage, for expenses associated with Intravascular Brachytherapy treatments.
The increasing number of heart diseases worldwide is also driving the need for IVBT to treat in stent restenosis—an issue where coronary arteries narrow again after stent placement—leading to a boost in the market, for these systems.
02

Restraint: High Costs and Reimbursement Issues

The high cost of an Intravascular Brachytherapy System poses a challenge for many healthcare facilities in low income countries as it deters them from investing in such advanced technologies due to financial constraints. Furthermore the market growth of these systems may face obstacles due to reimbursement issues that arise and the lack of insurance coverage, for patients who may opt out of receiving treatment as a result.
03

Opportunity: Technological Innovations Driving Adoption and Strategic Collaborations to Enhance Market Penetration

The market for Intravascular Brachytherapy System could see progress with advancements in technology that improve the effectiveness and safety of the system while making it more user friendly well. Implementing features such as enhanced radiation precision or better compatibility, with current vascular procedures has the potential to boost adoption among clinicians and drive market expansion significantly.
Working with cardiac care providers and medical facilities or partnering with companies that produce devices could help enhance the market reach of the IVBT by promoting it more effectively and ensuring it reaches a wider audience of patients, with vascular ailments through better distribution networks and integrated healthcare options.
04

Challenge: Technological Complexity and Training Requirements

The complex nature of IVBT requires training to ensure proper usage and effectiveness in medical settings. Providers incur expenses due to the specialized expertise required and the lengthy training period involved. The significant time and financial commitment, from healthcare professionals might act as a barrier that influences the acceptance rates and industry trends of IVBT.

Supply Chain Landscape

1

Raw Material Suppliers

Basf SEDow Chemical Company
2

Component Manufacturers

MedtronicBoston Scientific Corporation
3

System Assembly

Varian Medical SystemsCook Medical
4

Distribution & End-Users

HospitalsCardiovascular Centers
Intravascular Brachytherapy System - Supply Chain

Use Cases of Intravascular Brachytherapy System in Angioplasty Treatment & Coronary Heart Disease Treatment

Angioplasty Treatment : Intravascular Brachytherapy Systems are commonly utilized to address restenosis problems following angioplasty procedures. The Beta Radiation IVBT is known to be a treatment method as it hinders the growth of smooth muscle cells. Boston Scientific is a player in this field with their Beta Cath System being widely used by healthcare professionals due, to its precision and safety features.
Peripheral Artery Disease Management : When dealing with Peripheral Artery Disease medical professionals have been using IVBT to lower the chances of arteries getting blocked again after treatment. Modern systems like the Peripheral IVBT have proven effective in minimizing the risk of arteries narrowing again post treatment. Key companies, like Theragenics Corporation rely on their Novostea RX Brachytherapy System tailored for PAD cases to solidify their market presence.
Coronary Heart Disease Treatment : In the management of Coronary Heart Disease IVBT are essential for addressing problems with vessel renarrow ing that may occur after angioplasty or stenting procedures. The effectiveness of the Gamma Irradiation IVBT, in CH D treatment has been well demonstrated.

Recent Developments

Over the couple of years there have been impressive strides in the field of medicine with one standout achievement being the creation of the Intracoronary Brachytherapy. This advanced technology is crafted to administer targeted radiation to the blood vessels especially for addressing, in stent restenos is.

December 2024 : Medtronic shared results from trials, on their Intravascular Brachytherapy System. They have now upgraded it with cutting edge technology to enhance treatment effectiveness and improve comfort.
September 2024 : Siemens Healthineers introduced an Intravascular Brachytherapy System designed to improve the care of patients with in stent restensois. This represents a progress, in the field of medical radiation.
June 2024 : Boston Scientific Corporation has received clearance for its Intravascular Brachytherapy System aimed at addressing intricate cardiovascular conditions, with smooth operation and optimized efficiency.

Impact of Industry Transitions on the Intravascular Brachytherapy System Market

As a core segment of the Medical Device industry, the Intravascular Brachytherapy System market develops in line with broader industry shifts. Over recent years, transitions such as Increasing Adoption of NonInvasive Alternatives and Impact of AI and ML have redefined priorities across the Medical Device sector, influencing how the Intravascular Brachytherapy System market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Increasing Adoption of NonInvasive Alternatives

The field of IVBT is experiencing a move towards non invasive technologies that do not only require surgery and help lower the risk of infections – showing better performance in specific situations than traditional surgical approaches do. Additionally non invasive options provide recovery periods and less patient discomfort therefore leading to an increased acceptance, by healthcare professionals. The application of these systems is starting to influence the methods used by doctors in treating coronary artery disease and peripheral artery disease.
02

Impact of AI and ML

The rise of AI and ML in the healthcare sector has had an impact on the market for IVBT. These advanced algorithms play a role, in tailoring treatment plans forecasting treatment results and reducing medical expenses. By analyzing each patients data they enhance the effectiveness and productivity of IVBT treatments.